has served as an advisor or consultant within the past 12 months to Amgen Inc., Amylin Pharmaceuticals, Arisaph Pharmaceuticals Inc., Bayer Inc., Chugai Inc., Conjuchem Inc., Eli Lilly Inc., GlaxoSmithKline, Glenmark Pharmaceuticals, Johnson & Johnson, Merck Research Laboratories, Merck Fr., Novartis Pharmaceuticals, NPS Pharmaceuticals Inc., Phenomix Inc., Takeda., and Transition Pharmaceuticals Inc
It operates by targeting both GLP-1 and GIP receptors, which serve functions in regulating appetite and promoting satiety
It works by mimicking the GLP-1 hormone to reduce hunger and control blood sugar levels
This could be related to differences in ASTX-rich extract composition
The blend is studied for synergistic GH secretagogue research, combining GHRH receptor activation from CJC-1295 No DAC with selective GHRP activation from Ipamorelin for amplified pulsatile GH release